In this quick-fire Q&A, Dr. Pedro E. Hernández Director of Quality by Design at Merck Serono SA, shares his insights on Quality by Design adoption, ahead of the 11th annual PAT and Quality by Design in Pharma conference.What is the current state of Merck Serono`s QbD adoption? Merck Serono has both a QbD policy and a QbD guide and all new development projects, small molecules and biotech, are required to follow them. The result is a scientific, risk based approach, proactive ap…
With Product You Purchase
Subscribe to our mailing list to get the new updates!
Bharat Biotech’s Covaxin gets SEC approval on its Phase 3 trials efficacy data, Health News, ET HealthWorld
10 hours ago
12 hours ago
13 hours ago
14 hours ago